MPM BioImpact’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-151,750	Closed	-$3.68M	–	38
2022 Q1	$3.68M	Buy	151,750 +26,750	+21%	+$648K	0.99%	30
2021 Q4	$2.92M	Buy	+125,000	New	+$2.92M	0.53%	30